The IDF Virtual Congress 2021 will run over 6 days and include 66 hours of scientific sessions. It will feature more than 100 high-level speakers, including some of the top experts in diabetes today.
It will also feature 9 high-level satellite symposia. Don’t miss out on these excellent sources of additional education. These will also be available for view on-demand after the congress.
IDF is grateful to the following companies and organizations for their support at the IDF Virtual Congress 2021
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Founded in 1999 and headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom strives to simplify and improve diabetes management around the world. CGM systems are medical devices that can show patients’ glucose levels (including the rate of change and direction) throughout the day and night. Dexcom CGM reduces some of the guesswork that comes with making diabetes treatment decisions, offering our users’ greater peace of mind.
ENCORE MEDICAL EDUCATION is pleased to bring the significant science from the International Diabetes Federation Congress and the American Diabetes Association Scientific Sessions to health care professionals around the world through Best of IDF and Best of ADA meetings. These programmes offer the significant science presented at the meetings in a condensed format, to address the audience’s learning needs. The first Best of IDF-India meeting will be held on January 22-23, 2022 and is sponsored by Intas Pharmaceuticals. To register, please contact firstname.lastname@example.org.
To learn about industry sponsorship opportunities contact email@example.com.
Founded in 2000, i-SENS is a global company dedicated to improving the lives of people with diabetes and those who care for them. CareSens® is a recognized worldwide brand that provides fast and highly accurate blood glucose test results. With an annual production capacity of 2.1 billion test strips from highly efficient manufacturing facilities (two in Korea, one in China), i-SENS exports to over 110 countries including the USA, Japan, and Europe. Working closely with many healthcare professionals, i-SENS also supplies convenient POCT devices (HbA1c, Blood Gas, Electrolyte, PT/INR Analyzer) as well as Immunoassay Analyzer and CGMS which are launching in the near future.
The International Hypoglycaemia Study Group (IHSG) was founded in 2013. The IHSG grew out of a need to address the challenge of hypoglycaemia in diabetes. Despite significant advances in the medical treatment of diabetes, hypoglycaemia continues to pose a serious problem for many people living with diabetes and to place limits on glycaemic control. In addition to advancing the scientific understanding of hypoglycaemia, the IHSG seeks to create and disseminate solutions that will improve patients’ lives.
We are Merck, a vibrant science and technology company. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. The passion of our curious minds makes a positive difference to millions of people’s lives every day. In Healthcare, we discover unique ways to treat the most challenging diseases, such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information. Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live. We are curious minds dedicated to human progress
Ping An Insurance (Group) Company of China, Ltd. is a world-leading technology-powered retail financial services group. Finance and technology are our core businesses. While ensuring steady growth in our main financial businesses, we are increasing investment in technology to empower our main financial businesses with world-leading financial technology (fintech) and health technology (healthtech) capabilities. Ping An also uses its innovative technologies to support ecosystems: financial services, health care, auto services, and smart city services.
PingAn Smart Healthcare solutions have been deployed in more than 20,000 healthcare institutions, providing 100,000+ diagnosis and treatment recommendations to 600,000 physicians every day. 270 million medical images have been analyzed to help radiologists to read X-ray and CT.
SCIARC is characterised by innovative solutions that are committed to the rapid changes in medicine at the beginning of the 21st century. The company stands for competent knowledge transfer in medicine, which is expressed in the areas of medical education – CME and webcasts as well as medical writing and consulting. We also analyse complex research results with a view to clinical benefit and build the bridge to the correct implementation of scientific findings in clinics and medical practice.
Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 billion euros in 2020, Servier employs 22,500 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient’s voice at the heart of its activities, from research to support beyond the pill.
Worldwide Diabetes is a non-profit foundation dedicated to improving the lives of people with diabetes throughout the world by empowering health care professionals with training, education, and information on diabetes and cardiovascular disease. The aim of Worldwide Diabetes is to help shape the future of diabetes by educating health care professionals in the prevention, early detection, and management of diabetes in order to provide optimal care. The foundation delivers scientifically rigorous programs in all areas of the world and is led by a Board of Directors comprised of world-renowned experts in the fields of endocrinology and cardiology.
Request the IDF Virtual Congress 2021 Industry Prospectus
Complete the form below to request a copy of the industry prospectus, which includes information on all the sponsorship opportunities available at the IDF Virtual Congress 2021.
- More efficient use of budget (no travel, hotel, stand structure or catering costs)
- Participation of health professionals unable to attend in-person conferences due to financial and logistic barriers
- Lower registration rates open the meeting to a wider variety of researchers from diverse backgrounds and life experiences
- Acceleration of knowledge transfer and scientific innovation
- Better data on demographic, audience engagement and levels of networking
IDF Congresses attract a multi-disciplinary audience of health professionals. These include:
- Primary care physicians
- General surgeons
- Vascular surgeons
- Medical students
Learn more about our audience in the Congress library.
IDF is grateful to the following companies and organizations for having supported previous editions of the IDF Congress.
- American Association of Clinical Endocrinologists (AACE)
- Acon Laboratories
- Becton Dickinson
- Boehringer Ingelheim
- Cambridge Weight Plan
- Dasman Diabetes Institue
- Diabetes India
- Diabetic Foot Care India
- European Association for the Study of Diabetes
- Evia Medical Technologies
- Fred Hollows
- Hikma Pharmaceuticals
- Imperial College London Diabetes Centre
- Insulin for Life
- International Society for Pediatric and Adolescent Diabetes (ISPAD)
- LG Chem
- Lilly Diabetes
- Novo Nordisk
- Owen Mumford
- Pic Solutions/Artsana
- Roche Diabetes Care
- Sunstar Suisse SA
- The Diabetes Centre
- The Searle Company
- Tonghua Dongbao Pharmaceutical
- Trividia Health
- World Diabetes Foundation
- World Union of Wound Healing Societies